Viewing Study NCT00320658


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-01-02 @ 10:08 AM
Study NCT ID: NCT00320658
Status: COMPLETED
Last Update Posted: 2008-01-21
First Post: 2006-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module